Specialty Pharma Journal Specialty, Precision & Technology

MELBOURNE, Australia, Oct. 08, 2019 (GLOBE NEWSWIRE) — The US Food and Drug Administration (FDA) …

HOBOKEN, N.J.–(BUSINESS WIRE)–Octapharma USA today announced the U.S. Food and Drug Administration (FDA) has approved WILATE® for treatment of adults …

ROCKLAND, Mass., Oct. 8, 2019 /PRNewswire/ — EMD Serono, the biopharmaceutical business of Merck KGaA, …

Basel, October 8, 2019 — Novartis today announced that the U.S. Food and Drug Administration (FDA) …

DUBLIN, Oct. 08, 2019 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT) today announced it has received Breakthrough …

San Diego, California, Hilden, Germany and Germantown, Maryland – October 7, 2019 – Illumina, Inc. (NASDAQ: …

LEEDS, England, Oct. 8, 2019 /PRNewswire/ — 4D pharma plc (AIM: DDDD), a pharmaceutical company …

SPRING HOUSE, Pa., Oct. 7, 2019  — The Janssen Pharmaceutical Companies of Johnson & Johnson today …

LONDON and REDWOOD CITY, Calif., Oct. 07, 2019 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc …

CAMBRIDGE, Mass. and GAITHERSBURG, Md., Oct. 07, 2019 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: …

INDIANAPOLIS, Oct. 7, 2019 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that results from the global …

FOSTER CITY, Calif.–(BUSINESS WIRE)–Oct. 3, 2019– Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S. Food and …

FRIENDSWOOD, Texas–(BUSINESS WIRE)–Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic …

BOSTON and NEW YORK, Oct. 07, 2019 (GLOBE NEWSWIRE) — Akcea Therapeutics, Inc. (NASDAQ: AKCA), …

NORTH BILLERICA, Mass. & NEW YORK–(BUSINESS WIRE)–Lantheus Holdings, Inc. (NASDAQ: LNTH) (“Lantheus”), parent company of …